SummaryThe targeted DNA and RNA sequencing market is maturing into a cornerstone of precision biology and clinical research, enabling focused interrogation of genomic regions and transcriptomic signals with high sensitivity and cost efficiency. Driven by advances in sequencing chemistry, panel design, and computational pipelines, targeted approaches are increasingly used across oncology, rare...